Stay updated on Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Sign up to get notified when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.

Latest updates to the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedUpgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check35 days agoChange DetectedThe page shifts its focus to a broader Ovarian Cancer topic with a new v3.1.0 revision, while removing older, more granular histologic terms and a v3.0.2 tag. This indicates an updated, streamlined content branding rather than adding new substantive details.SummaryDifference0.9%

- Check50 days agoChange DetectedThe page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has added significant information regarding drug efficacy and safety related to colorectal and ovarian cancers, including a detailed citation of a study. Additionally, the facility name and location have been updated, while several specific cancer-related terms and topics have been removed.SummaryDifference9%

- Check78 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.